SCHEMBL1633587

SCHEMBL1633587

NS(=O)(=O)c1ccc(Nc2ncc3cccc(CNCc4cccnc4)c3n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 3/20 0.49
▸ NTRK1 P04629 1/20 0.47
▸ CA2 P00918 3/20 0.47
▸ CCNT1 O60563 3/20 0.47
▸ CDK1 P06493 3/20 0.47
▸ CCNB1 P14635 3/20 0.47
▸ CDK9 P50750 3/20 0.47
▸ PTK2 Q05397 3/20 0.46
▸ CDK7 P50613 2/20 0.44
▸ CCNH P51946 2/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ IKBKB O14920 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ NCOA3 Q9Y6Q9 1/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633586 0.91 CA1 (0.51) NTRK1CA2CCNT1CDK1CCNB1
SCHEMBL13498245 0.84 CDK2 (0.48) NTRK1CA2CCNT1CDK1CCNB1
SCHEMBL1632328 0.79 CA2 (0.50) NTRK1CA2CCNT1CDK1CCNB1
SCHEMBL1633146 0.79 CA1 (0.49) NTRK1CA2CCNT1CDK1CCNB1
SCHEMBL1633321 0.78 CA1 (0.48) NTRK1CA2CCNT1CDK1CCNB1
SCHEMBL1632468 0.77 MEN1 (0.55) CA2CCNT1CDK1CCNB1CDK9
SCHEMBL1634272 0.77 CA2 (0.49) CA2CCNT1CDK1CCNB1CDK9
SCHEMBL1633835 0.76 IKBKB (0.47) NTRK1CA2CCNT1CDK1CCNB1
SCHEMBL1633856 0.76 PTK2 (0.48) NTRK1CA2CCNT1CDK1CCNB1
SCHEMBL1634500 0.76 SYK (0.49) NTRK1CA2CCNT1CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback